ENDORSE THE PERSONALIZED HEALTH MANIFESTO!

Read the Manifesto

Join leaders in the life sciences and others in calling for the acceleration of an era of personalized health by endorsing the Manifesto. Below are the names of people who have endorsed the manifesto so far.

Endorse the Manifesto here.

Read the 82-page study that supports the manifesto - it details the barriers and some solutions to accelerating the pace of personalized health and medicine for all of us. The study was developed with the input of 36 life science leaders (see the list here - see pages 5-6).

Duncan, David Ewing, Frank Douglas, Stephen Spielberg, Linda Molnar, "Personalized Health Project: Identifying the gaps between discovery and application in the life sciences, and proposed solutions", Kauffman Foundation, January, 2011.

ADAM GAZZALEY, MD, PhD, neurologist and neuroscientist, University of California at San Francisco
ANTHONY ATALA, MD, director, Regenerative Medicine Foundation
ATUL BUTTE, MD, PhD, geneticist and bioinformaticist, Stanford University Medical School
BROOK BYERS, MBA, venture capitalist, Kleiner Perkins Caufield & Byers
CHRIS AUSTIN, MD, neurologist; director, Chemical Genomics Center, National Institutes of Health
DANIEL KRAFT, MD, PhD, oncologist; stem cell researcher, Stanford University Medical School
DAVID AGUS, MD, oncologist, proteomics researcher, entrepreneur, University of Southern California; co-founder, Navigenics
DAVID EWING DUNCAN, journalist and life science policy analyst; director, The Center for Life Science Policy, UC Berkeley
DIETRICH STEPHAN, PhD, geneticist; director, Ignite Institute; co-founder, Navigenics
EDWARD ABRAHAMS, PhD, president, Personalized Medicine Coalition
ERIC SCHADT, PhD, biocomputationist; chief scientific officer, Pacific Biosciences; co-founder, Sage Bionetworks
ERIC TOPOL, MD, cardiologist and translational geneticist; director, Scripps Translational Science Institute
FRANK DOUGLAS, MD, PhD, president and chief executive officer, Austen BioInnovation Institute of Akron, Ohio; founder and first executive director of the MIT Center for Biomedical Innovation, Massachusetts Institute of Technology; former chief scientific officer, Aventis
FRED FRANK, MBA, life sciences investment banker; vice chairman, Peter J. Solomon Company; former vice chairman, Lehman Brothers
GEORGE CHURCH, PhD, molecular biologist, professor of Genetics, and director, Center for Computational Genetics, Harvard Medical School
GEORGE POSTE, PhD, researcher, policy analyst, and former pharmaceutical executive; Chief Scientist, Complex Adaptive Systems Initiative and professor of Health Innovation, Arizona State University; former President, R&D, of SmithKline Beecham
GREG SIMON, JD, senior vice president for Worldwide Policy, Pfizer; former president, Faster Cures; former chief domestic policy advisor to Vice President Al Gore
GREGORY STOCK, PhD, MBA, founding CEO, Signum Biosciences; founding director, Program on Medicine, Technology and Society, University of California at Los Angeles School of Medicine
HANK GREELY, JD, professor of Law, Stanford University; director, Center for Law and the Biosciences
JAMES HEYWOOD, co-founder and chairman, PatientsLikeMe
JAMES THOMSON, VMD, PhD, stem cell scientist; director of Regenerative Biology, The Morgridge Institute for Research, University of Wisconsin School of Medicine and Public Health
JOSHUA ADLER, MD, physician, chief medical officer, University of California at San Francisco Medical Center
LEE HOOD, MD, PhD, molecular biologist and bioinformaticist; founder and director, Institute for Systems Biology
MARGARET ANDERSON, executive director, FasterCures
MARTYN SMITH, PhD, professor of Toxicology, School of Public Health, Division of Environmental Health Sciences, University of California Berkeley
MICHAEL ROIZEN, MD, preventive medicine; director, Wellness Institute, Cleveland Clinic
MISHA ANGRIST, PhD, assistant professor, Duke University Institute for Genome Sciences & Policy
NATHANIEL DAVID, PhD, entrepreneur and venture capitalist; venture partner, Arch Venture Partners
PAUL BILLINGS, MD, PhD, clinical geneticist; director, Genomic Medicine Institute, El Camino Hospital
RAY WOOSLEY, MD, PhD, president and CEO, Critical Path Institute
SAFI BAHCALL, PhD, CEO, Synta, Inc.
STEPHEN FRIEND, MD, PhD, president, CEO, co-founder, Sage Bionetworks; former senior vice president and franchise head for Oncology Research, Merck
STEPHEN SPIELBERG, MD, PhD, pediatrician; director, Center for Personalized Medicine and Therapeutic Innovation, Children's Mercy Hospital, Kansas City, Missouri; former dean, Dartmouth Medical School
STEVE WIGGINS, venture capitalist and former health insurance executive; managing director of Essex Woodlands Health Ventures; founder and former CEO, Oxford Health Plans
ZACK LYNCH, executive director, Neurological Industry Organization